A Deep‐Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes
Key claim: A deep-learning biomarker of systemic cellular senescence burden predicts mortality and health outcomes.
Abstract
Aging Cell, Volume 25, Issue 10, October 2026.
Why this matters
Senescent-cell burden has been a mechanistically important but hard-to-measure target; most existing readouts are imaging probes or single analytes without outcome linkage. A deep-learning composite that ties systemic senescence signals to mortality moves the field toward an outcome-anchored senescence metric, which matters because senolytic trials currently lack a validated pharmacodynamic biomarker. As with any clock, associating the score with mortality is not the same as showing that moving it reflects reduced senescent burden or extended healthspan.